ACADIA Pharmaceuticals Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
ACADIA Pharmaceuticals has a total shareholder equity of $516.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $914.1M and $397.4M respectively. ACADIA Pharmaceuticals's EBIT is $22.8M making its interest coverage ratio -1.1. It has cash and short-term investments of $500.9M.
Anahtar bilgiler
0%
Borç/özkaynak oranı
US$0
Borç
| Faiz karşılama oranı | -1.1x |
| Nakit | US$500.94m |
| Eşitlik | US$516.70m |
| Toplam yükümlülükler | US$397.40m |
| Toplam varlıklar | US$914.10m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 0A4W's short term assets ($728.9M) exceed its short term liabilities ($337.9M).
Uzun Vadeli Yükümlülükler: 0A4W's short term assets ($728.9M) exceed its long term liabilities ($59.5M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 0A4W is debt free.
Borcun Azaltılması: 0A4W has not had any debt for past 5 years.
Borç Kapsamı: 0A4W has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 0A4W has no debt, therefore coverage of interest payments is not a concern.